To confirm the presence of Pten and p53 edits causing the disruption of the two targeted tumor suppressor genes, DNA extracted from one primary tumor (located in the uterus) and one metastatic outgrowth was submitted to Amplicon Next Generation Sequencing (NGS) (Figure 7B). The gene discussed is TP53; the disease is neoplasm.